TransMedics (TMDX) Change in Account Payables (2018 - 2026)
TransMedics' (TMDX) quarterly Change in Account Payables came in at $1.1 million in Q1 2026, up 44.17% year-on-year from $781000.0 in Q1 2025, and up 154.55% quarter-over-quarter from -$2.1 million in Q4 2025.
TransMedics (TMDX) Change in Account Payables (2018 - 2026) Analysis & Trends
TransMedics' Change in Account Payables history runs 9 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- On a quarterly basis, Change in Account Payables rose 44.17% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $326000.0, a 77.11% decrease from a year earlier, with the FY2025 full-year figure at -$19000.0, up 98.64% from the prior year.
- Change in Account Payables rose to $1.1 million in Q1 2026 per TMDX's latest filing, from -$2.1 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $3.8 million in Q2 2024 and bottomed at -$4.0 million in Q1 2022.
- The 5-year median for Change in Account Payables is $416000.0 (2023), against an average of $199882.4.
- Across the five-year window, Change in Account Payables tumbled 4793.9% in 2022 and soared 6919.44% in 2025, its largest moves.
- Year by year, Change in Account Payables stood at $264000.0 in 2022, then soared by 57.58% to $416000.0 in 2023, then sank by 854.33% to -$3.1 million in 2024, then jumped by 34.23% to -$2.1 million in 2025, then soared by 154.55% to $1.1 million in 2026.
- Per Business Quant, the three latest TMDX Change in Account Payables figures stand at $1.1 million (Q1 2026), -$2.1 million (Q4 2025), and $2.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TransMedics | 2.45 Bn | 1.98 Bn | 101.16 Mn | 1.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.13 Mn |
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | -2.06 Mn |
| Dec 31, 2025 | -2.06 Mn |
| Sep 30, 2025 | 2.46 Mn |
| Sep 30, 2025 | 2.46 Mn |
| Jun 30, 2025 | -1.19 Mn |
| Jun 30, 2025 | -1.19 Mn |
| Mar 31, 2025 | 781,000.00 |
| Mar 31, 2025 | 781,000.00 |
| Dec 31, 2024 | -3.14 Mn |
| Dec 31, 2024 | -3.14 Mn |
| Sep 30, 2024 | -36,000.00 |
| Sep 30, 2024 | -36,000.00 |
| Jun 30, 2024 | 3.82 Mn |
| Jun 30, 2024 | 3.82 Mn |
| Mar 31, 2024 | -2.04 Mn |
| Mar 31, 2024 | -2.04 Mn |
| Dec 31, 2023 | 416,000.00 |
| Dec 31, 2023 | 416,000.00 |